Clinical Trial

The Prognosis Effect of Indocyanine Green (ICG) Fluorescence Guided Surgery on Disease-free Survival (DFS) of Stage III Colorectal Cancer

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
Previous studies of Indocyanine green (ICG) in colorectal surgery have focused on lymphatic mapping, lymph node detection, and the number of harvested lymph nodes. However, relatively few studies have evaluated the outcomes of this imaging technology, especially the prognosis following of colorectal cancer resection. The present study assessed the prognosis of stage III colorectal cancer patients following ICG fluorescence-guided surgery as compared to conventional surgery without the use of ICG Fluorescence imaging
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-09-02.
Status change: Not Yet Recruiting → Enrolling by Invitation 2026-06-17
Trial Details
NCT Number NCT06583564
Lead Sponsor Shanghai Tong Ren Hospital
Conditions Colorectal Cancer Stage III
Enrollment 192 participants
Start Date 2024-09-27
Primary Completion 2028-03-31 (estimated)
Study Completion 2028-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-22